Switch View
© Globe Newswire
21.10.2025
ISIN: US2210061097
CorVel Corp
CRVL
LISTED
NASDAQ
CorVel Corporation to Host Live Earnings Release Webcast
News Preview
FORT WORTH, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, November 4, 2025, at 11:30 AM Eastern Time. During the webcast, CorVel will also...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
News Preview
Study to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735
Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens to be Evaluated
SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Viking...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
LYVDELZI® (SELADELPAR) RECEIVES HEALTH CANADA APPROVAL FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS
News Preview
–
LYVDELZI is the Only Medicine to Demonstrate Statistically Significant and Durable Improvements in Both Pruritus and Markers of Cholestasis Related to the Risk of Disease Progression in a Phase 3 Trial
–...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
21.10.2025
ISIN: US85916J4094
Stereotaxis Inc
STXS
LISTED
XASE
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
News Preview
ST. LOUIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 third quarter on Tuesday, November 11, 2025 at the close of the U.S. financial markets. The Company will host...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
21.10.2025
ISIN: CA68405H1001
Optimi Health Corp
OPTI
LISTED
CSE
Optimi Health Provides Corporate Update
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of pharmaceutical psychedelics including MDMA and naturally-derived psilocybin, is pleased to announce that it has passed its Drug Establishment Licence (DEL) inspect...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
News Preview
Third quarter revenues of $2.82 billion, up 13.1% from 2024
Third quarter reported diluted earnings per share ("EPS") of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024
Year-to-date cash provided by operations of $1.4 billion, up 63.1% from 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in U.S. Adults
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from a systematic literature review of studies on the epidemiology and antimicrobial resistance (AMR) of pneumococcal serotypes covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in U.S. adults. The evaluation examine...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: US58502B1061
Pediatrix Medical Group Inc
MD
LISTED
NYSE
Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025
News Preview
Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Monday, November 3, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2025. A detailed press release will be issued the morning of November 3, 2025 before the securities markets open.
The investor conference cal...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US6951271005
Pacira Biosciences Inc
PCRX
LISTED
NASDAQ
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
News Preview
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a Paragraph IV Certification Notice Letter (PIV Notice) from The WhiteOak Group, a subsidiary of a sma...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US23954D1090
Day One Biopharmaceuticals Inc
DAWN
LISTED
NASDAQ
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
News Preview
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, No...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US64131A1051
Neuronetics Inc
STIM
LISTED
NASDAQ
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call
News Preview
MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, the leading provider of Transcranial Magnetic Simu...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
21.10.2025
ISIN: US34960Q3074
Fortress Biotech Inc
FBIO
LISTED
NASDAQ
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
News Preview
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys Therapeutics, Inc. (“Crystalys”), in which Urica maintains an equity position, dosed first patients in its two randomized, double-blind, multicenter global Ph...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: US8064071025
Henry Schein Inc
HSIC
LISTED
NASDAQ
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET
News Preview
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2025 financial results before the stock market opens on Tuesday, November 4, 2025, and will provide a live webcast of its earnings conference call on the s...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned E...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Commences Tender Offer for All Issued and Outstanding Common Shares of Merus N.V.
News Preview
Media ReleaseCOPENHAGEN, Denmark; October 21, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Notice convening an Extraordinary General Meeting of Novo Nordisk A/S
News Preview
Bagsværd, Denmark, 21 October 2025 – Further to company announcement no. 28 issued today, an Extraordinary General Meeting of Novo Nordisk A/S is called to elect new members to the Board of Directors in accordance with the meeting agenda and proposals included in the enclosed meeting notice....
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: US0367521038
Elevance Health Inc
ANTM
LISTED
NYSE
Elevance Health Reports Third Quarter 2025 Results
News Preview
Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results.
"Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we’re focused on advancing affordability and elevating the member experience through our growing value-based care partnersh...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US34385P1084
Standard BioTools Inc
LAB
LISTED
NASDAQ
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
News Preview
WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with the appointments of Adam Villa as Senior Vice President, Technical Operations, and Ashley Jones as...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US8294011080
Sionna Therapeutics Inc
SION
LISTED
NASDAQ
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
News Preview
SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US7504911022
RadNet Inc
RDNT
LISTED
NASDAQ
RadNet to Host Investor Day on November 11, 2025
News Preview
LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of outpatient imaging centers and digital health and AI solutions, today announced that it will host an Investor Day at the Nasdaq MarketSite in New York City on Tues...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025
News Preview
Bayer will present methods and baseline characteristic data from the global Phase III OCEANIC-STROKE study with the investigational agent asundexian, in a late-breaking presentation at the upcoming 17th World Stroke Congress, being held in Barcelona, Spain from October 22 – 24.
Bayer presentations on OCEANIC-STROKE include:
Factor XIa (FXIa)...
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica strengthens basic care with new pharmacy concept
News Preview
Galenica AG
/ Key word(s): Product Launch
Galenica strengthens basic care with new pharmacy concept 21.10.2025 / 07:55 CET/CEST
Press release
Pharmacies play a key role in healthcare.
Galenica is testing a new pharmacy concept with a focus on consultations and customer experience at the Amavita pharmacy in Zurich’s Glattzent......
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica stärkt Grundversorgung mit neuem Apothekenkonzept
News Preview
Galenica AG
/ Schlagwort(e): Produkteinführung
Galenica stärkt Grundversorgung mit neuem Apothekenkonzept 21.10.2025 / 07:55 CET/CEST
Medienmitteilung
Apotheken übernehmen eine zentrale Rolle im Gesundheitswesen.
Galenica testet in der Amavita Apotheke im Glattzentrum Zürich ein neues Apothekenkonzept mit Fokus auf Beratung ......
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: IS0000000040
Embla Medical hf
EMBLA
LISTED
CPH
Embla Medical hf: Interim Report Q3 2025
News Preview
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ --
Announcement no. 49/2025
Interim report Q3 2025
21 October 2025
Sveinn...
Themefolio
Profiler
Peergroup
© Newsfile
21.10.2025
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo Pharmaceuticals Receives Regulatory Approval by the European Commission for Winlevi(R) in the EU, Following on the Positive CHMP Opinion
News Preview
Dublin, Ireland--(Newsfile Corp. - October 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Commission has granted regulatory approval in the EU for Winlevi® (clascoterone 1% cream) for the treatment of acne vulgaris in both adults an...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: IS0000000040
Embla Medical hf
EMBLA
LISTED
CPH
Embla Medical hf: Interim Report Q3 2025
News Preview
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ --
Announcement no. 49/2025
Interim report Q3 2025
21 October 2025
Sveinn...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.10.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
News Preview
NeuralCloud Solutions to deploy its CardioYield™ platform in a multi-stage pilot program with a full-service cardiology clinic in Canada.Enhance Holter ECG analysis accuracy, efficiency, and workflow automation through advanced AI signal processing. TORONTO, ON / ACCESS Newswire / October 21, 2025 / AI/ML Innovations Inc. ("AIML" or...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.10.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
News Preview
Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir's foundation for partnerships, licensing, and long-term value creation. MIAMI, FLORIDA / ACCESS Newswire / October 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"),...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: JP3431300007
Nxera Pharma Co Ltd
45650
LISTED
XJPX
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
News Preview
Tokyo, Japan and Cambridge, UK, 21 October 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) announces that its partner, Cancer Research UK, presented data from the successfully completed Phase 1 part of the ongoing Phase 1/2a clinical trial (NCT05944237) of Nxera’s immunotherapy drug HTL0039732 (also known as NXE0039732) at the European So...
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova baut KI-Führungsposition aus und lanciert Innovationen an der
EUHA 2025
News Preview
Sonova Holding AG
/ Schlagwort(e): Produkteinführung
Sonova baut KI-Führungsposition aus und lanciert Innovationen an der
EUHA 2025
21.10.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Schweiz), 21. Oktober 2025 – Sonova Holding AG (SWX: SOON) baut ihre Führungsrolle beim Einsatz Künstlicher Intelligen......
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova expands AI leadership with innovations debuting at
EUHA 2025
News Preview
Sonova Holding AG
/ Key word(s): Product Launch
Sonova expands AI leadership with innovations debuting at
EUHA 2025
21.10.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Switzerland), October 21, 2025 – Sonova Holding AG (SWX: SOON), takes its AI leadership in hearing care further by introducing Infinio......
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
FYB201/Ranivisio® ist das erste Ranibizumab-Biosimilar Europas in einer Fertigspritze
News Preview
Pressemitteilung // 21. Oktober 2025
Formycon setzt neuen Standard: FYB201/Ranivisio® ist das erste Ranibizumab-Biosimilar Europas in einer Fertigspritze
Innovative Fertigspritze (PFS) für intravitreale Injektionen¹ bietet verbessertes Handling sowie hohe Dosiergenauigkeit und Anwenderfreundlichkeit
Teva Pharmaceutical Industries Ltd. übernimm......
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe
News Preview
Press Release // October 21, 2025
Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe
Innovative pre-filled syringe (PFS) with high standards for intravitreal injections1 offers improved handling, high dosing accuracy and greater convenience for applicants
Teva Pharmac......
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: BE0003818359
Galapagos NV
GLPG
LISTED
EURONEXT
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
News Preview
Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Oct. 20, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beha...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
News Preview
WATERTOWN, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the pricing of the upsized underwritten offering of sha...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Deadline: Rosen Law Firm Urges Nutex Health Inc. (NASDAQ: NUTX) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025. Nutex describes itself as a “physician-led, healthcare services and operations company.”
For more information, submit a...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: KR7326030004
SK Biopharmaceuticals Co Ltd
326030
LISTED
KOE
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
News Preview
SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization.
SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusin...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO
News Preview
NEW YORK, Oct. 20, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONS
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding unsecured conve...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONS
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 20, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding unsecured convertible...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR ALERT: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period"), have until December 15, 2025 to seek appointment...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Oct. 20, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2025
ISIN: US10950A1060
Brightspring Health Services Inc.
BTSG
LISTED
NASDAQ
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
News Preview
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 20, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASD...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today issued the following letter to the Board of Directors of STAAR regarding Yunqi’s opposition to the proposed sale to Alcon Inc. (...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards on (i) October 17, 2025, covering an aggregate of 1,579,500 shares of its common stock, consisting of stock options to purchase an aggregate of 1,553,000 shares of common stock, and restricted stock units (“RSUs”) repres...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
DocGo Acquires Virtual Care Platform SteadyMD, Expands Telehealth Services Across All 50 States
News Preview
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it has acquired virtual care platform SteadyMD, Inc. Management will host a conference call and webcast on Tuesday, October 21 at 11:00 a.m. ET to discuss this acquisition.
SteadyM...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
News Preview
NEW YORK, Oct. 20, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beha...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
ISIN: US00404A1097
Acadia Healthcare Company Inc
ACHC
LISTED
NASDAQ
Acadia Healthcare Announces Date for Third Quarter 2025 Earnings Release
News Preview
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2025 results on Wednesday, November 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, November 6, 2025. A live broadcast of the conference call will...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on Monday, November 3, 2025, at 4:30 p.m. ET to discuss its financial results and business updates for the third quarter of 2025.
Investors and the general p...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Report Third Quarter Financial Results on October 28, 2025
News Preview
DUBLIN, Oct. 20, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (12:00 p.m. GMT) on Tuesday, Oct. 28, 2025 to discuss the company's third quarter financial results.
The webcast player and accompanying slides may be accessed on...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Report Third Quarter Financial Results on October 28, 2025
News Preview
DUBLIN, Oct. 20, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (12:00 p.m. GMT) on Thursday, Oct. 23, 2025 to discuss the company's third quarter financial results.
The webcast player and accompanying slides may be accessed on...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
ISIN: US42225T1079
Health Catalyst Inc
HCAT
LISTED
NASDAQ
Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025
News Preview
SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close. In conjunction, the company will host a con...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
ISIN: US10950A1060
Brightspring Health Services Inc.
BTSG
LISTED
NASDAQ
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
News Preview
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Rob...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
ISIN: US10950A1060
Brightspring Health Services Inc.
BTSG
LISTED
NASDAQ
BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
News Preview
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced preliminary financial results for the third quarter ended September 30, 2025, increased Revenue and Adjusted...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
ISIN: US8257041090
SI-BONE Inc
SIBN
LISTED
NASDAQ
SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025
News Preview
SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third quarter of 2025 after market close on Monday, November 10, 2025. Management will host a conference call beginning at 1:30 p.m. Paci...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
ISIN: US87357P1003
Tactile Systems Technology Inc
TCMD
LISTED
NASDAQ
Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025
News Preview
MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2025 financial results will be released after the market closes on Monday, November...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
